CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
Universitat de Barcelona
Barcelona, EspañaPublications in collaboration with researchers from Universitat de Barcelona (9)
2024
-
Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023
Neurologia, Vol. 39, Núm. 2, pp. 196-208
-
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside Attacks
Neurology, Vol. 103, Núm. 6
2022
-
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
Frontiers in immunology, Vol. 13, pp. 842354
-
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
Neurologia, Vol. 37, Núm. 8, pp. 615-630
2021
-
Artificial intelligence extension of the OSCAR-IB criteria
Annals of Clinical and Translational Neurology, Vol. 8, Núm. 7, pp. 1528-1542
-
Natalizumab, Fingolimod, and Dimethyl Fumarate Use and Pregnancy-Related Relapse and Disability in Women With Multiple Sclerosis
Neurology, Vol. 96, Núm. 24, pp. E2989-E3002
2020
-
A call for a global COVID-19 Neuro Research Coalition
The Lancet Neurology
2019
-
Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial
Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Núm. 17, pp. 8463-8470
2016
-
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus
Neurology: Neuroimmunology and NeuroInflammation, Vol. 3, Núm. 3